Carles Codony

1.9k citations

29 papers · 1.2k indexed · h-index 13

Impact in

Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Molecular Biology top 10%
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- RNA modifications and cancer
- RNA Research and Splicing
- RNA and protein synthesis mechanisms

Papers in ⓘ

Pathology and Forensic Medicine 11
- Cancer Mechanisms and Therapy 6
- Lymphoma Diagnosis and Treatment 5
Clinical Biochemistry 3
- Metabolism and Genetic Disorders 3

Co-authors: John Byrne (1 shared paper)Andrew J. Hamilton (1 shared paper)Gurman S. Pall (1 shared paper)Rafael Rosell (16 shared papers)Niki Karachaliou (15 shared papers)Jordi Codony‐Servat (12 shared papers)Dolors Serra (4 shared papers)Guillermina Asins (4 shared papers)
Journals: Journal of Thoracic Oncology (4 papers)Blood (3 papers)Translational Lung Cancer Research (3 papers)Nature Communications (2 papers)Biochemical Society Transactions (2 papers)
Partner nations: Spain Italy United States

In The Last Decade

Carles Codony

27 papers receiving 1.2k citations

Peers

Countries citing papers authored by Carles Codony

Since Specialization

Citations

This map shows the geographic impact of Carles Codony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carles Codony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carles Codony more than expected).

Fields of papers citing papers by Carles Codony

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carles Codony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carles Codony. The network helps show where Carles Codony may publish in the future.

Co-authors

The 25 scholars most cited alongside Carles Codony, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carles Codony Line = papers co-authored together Carles Codony links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Carbodiimide-mediated cross-linking of RNA to nylon membranes improves the detection of siRNA, miRNA and piRNA by northern blot Nucleic Acids Research ·Gurman S. Pall, Carles Codony, John Byrne, L. Ritchie, Andrew J. Hamilton	2007	386
2	Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma Blood ·Alfons Navarro, Tania Díaz, Antonio Martı́nez, Anna Gayà, Aina Pons, Bernat Gel, Carles Codony, Gerardo Ferrer, Carmen Martı́nez, Emili Montserrat, Mariano Monzó	2009	135
3	Natural trans - splicing in carnitine octanoyltransferase pre-mRNAs in rat liver Proceedings of the National Academy of Sciences ·C. Caudevilla, Dolors Serra, Angel Miliar, Carles Codony, Guillermina Asins, M.A. Bach, Fausto G. Hegardt	1998	120
4	Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer Nature Communications ·Kirstine Jacobsen, Jordi Bertrán-Alamillo, Miguel Ángel Molina‐Vila, Cristina Teixidó, Niki Karachaliou, Martin H. Pedersen, Josep Castellví, Mónica Garzón, Carles Codony, Jordi Codony‐Servat, Ana Giménez‐Capitán, Ana Drozdowskyj, Santiago Viteri, Martin R. Larsen, Ulrik Lassen, Enriqueta Felip, Trever G. Bivona, Henrik J. Ditzel, Rafael Rosell	2017	118
5	AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy Nature Communications ·Jordi Bertrán-Alamillo, Valérie Cattan, Marie Schoumacher, Jordi Codony‐Servat, Ana Giménez‐Capitán, F. Cantero, Mike F. Burbridge, Sónia Rodríguez, Cristina Teixidó, Ruth Román, Josep Castellví, Silvia García-Román, Carles Codony, Santiago Viteri, Andrés F. Cardona, Niki Karachaliou, Rafael Rosell, Miguel-Angel Molina-Vila	2019	88
6	ZAP-70 enhances migration of malignant B lymphocytes toward CCL21 by inducing CCR7 expression via IgM-ERK1/2 activation Blood ·Eva Calpe, Carles Codony, Maria João Baptista, Pau Abrisqueta, Cecilia Carpio, Noelia Purroy, Francesc Bosch, Marta Crespo	2011	52
7	Cancer Stem Cell Biomarkers in EGFR-Mutation–Positive Non–Small-Cell Lung Cancer Clinical Lung Cancer ·Jordi Codony‐Servat, Carles Codony, Andrés F. Cardona, Ana Giménez‐Capitán, Ana Drozdowskyj, Jordi Berenguer, Jillian Wilhelmina Paulina Bracht, Masaoki Ito, Niki Karachaliou, Rafael Rosell	2019	39
8	Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC) Oncotarget ·Carles Codony, Jordi Codony‐Servat, Niki Karachaliou, Miguel Ángel Molina‐Vila, Imane Chaib, José Luis Ramírez, María de los Llanos Gil, Flavio Solca, Trever G. Bivona, Rafael Rosell	2017	38
9	Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma Cell Communication and Signaling ·Masaoki Ito, Carles Codony, Jordi Codony‐Servat, David Lligé, Imane Chaib, Xiaoyan Sun, Miao Jing, Rongwei Sun, Xueting Cai, Alberto Verlicchi, Morihito Okada, Miguel Ángel Molina‐Vila, Niki Karachaliou, Peng Cao, Rafael Rosell	2019	35
10	RNA secondary structure mediates alternative 3′ss selection in Saccharomyces cerevisiae RNA ·Mireya Plass, Carles Codony, Pedro G. Ferreira, Josep Vilardell, Eduardo Eyras	2012	34
11	Osimertinib and pterostilbene in EGFR-mutation-positive non-small cell lung cancer (NSCLC) International Journal of Biological Sciences ·Jillian Wilhelmina Paulina Bracht, Niki Karachaliou, Jordi Berenguer, Carlos Pedraz‐Valdunciel, Martyna Filipska, Carles Codony, Jordi Codony‐Servat, Rafael Rosell	2019	28
12	Gene expression profiling in chronic lymphocytic leukaemia Best Practice & Research Clinical Haematology ·Carles Codony, Marta Crespo, Pau Abrisqueta, Emili Montserrat, Francesc Bosch	2009	17
13	Hsp90 inhibitors enhance the antitumoral effect of osimertinib in parental and osimertinib-resistant non-small cell lung cancer cell lines Translational Lung Cancer Research ·Jordi Codony‐Servat, Santiago Viteri, Carles Codony, Masaoki Ito, J. Bracht, Jordi Berenguer, Imane Chaib, Miguel Ángel Molina‐Vila, Niki Karachaliou, Rafael Rosell	2019	14
14	PIM-1 inhibition with AZD1208 to prevent osimertinib-induced resistance in EGFR-mutation positive non-small cell lung cancer Journal of Cancer Metastasis and Treatment ·Jillian Wilhelmina Paulina Bracht, Niki Karachaliou, Jordi Berenguer, Manuel Fernández-Bruno, Martyna Filipska, Carlos Pedraz‐Valdunciel, Carles Codony, Jordi Codony‐Servat, Rafael Rosell	2019	12
15	SRC and PIM1 as potential co-targets to overcome resistance in MET deregulated non-small cell lung cancer Translational Lung Cancer Research ·Ilaria Attili, Laura Bonanno, Niki Karachaliou, Jillian Wilhelmina Paulina Bracht, Jordi Berenguer, Carles Codony, Jordi Codony‐Servat, Erika Aldeguer, Ana Giménez‐Capitán, Alessandro Dal Maso, Matteo Fassan, Imane Chaib, Miguel Ángel Molina‐Vila, Antonio Passaro, Filippo de Marinis, Giulia Pasello, Valentina Guarneri, Pierfranco Conté, Rafael Rosell	2020	11
16	Targeting PKCι-PAK1 in EGFR-mutation positive non-small cell lung cancer Translational Lung Cancer Research ·Masaoki Ito, Carles Codony, Niki Karachaliou, Rafael Rosell	2019	11
17	Modulation in vitro of H-ras oncogene expression by trans-splicing Oncogene ·Carles Codony, Sònia Guil, C. Caudevilla, Dolors Serra, Guillermina Asins, A. Graessmann, Fausto G. Hegardt, Montse Bach-Elias	2001	6
18	Differential Gene Expression Profile Associated to Apoptosis Induced by Dexamethasone in CLL Cells According to IGHV/ZAP-70 Status Clinical Cancer Research ·Maria João Baptista, Ana Muntañola, Eva Calpe, Pau Abrisqueta, Olga Salamero, Eva Fernández, Carles Codony, Eva Giné, Susana G. Kalko, Marta Crespo, Francesc Bosch	2012	4
19	SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy International Journal of Molecular Sciences ·J.J. Soto Castillo, Lucía Llavata-Marti, Roser Fort‐Culillas, P. Andreu Cobo, Rafael Moreno, Carles Codony, Xavier García del Muro, Ramón Alemany, Josep M. Piulats, Juan Martín-Liberal	2023	4
20	Biological Analysis and Prognostic Significance of Proliferative Cellular Compartment in Chronic Lymphocytic Leukemia (CLL). Blood ·Pau Abrisqueta, Neus Villamor, Ana Muntañola, Carles Codony, Mireia Camós, Eva Calpe, Maria João Baptista, Gonzalo Gutiérrez, Xavier Calvo, Rita Coutinho, Gabriela Ghita, Carol Moreno, Cristina López, Olga Salamero, Emili Montserrat, Francesc Bosch	2009	3

About Carles Codony

Carles Codony is a scholar working on Pathology and Forensic Medicine, Clinical Biochemistry, Pulmonary and Respiratory Medicine, Genetics and Oncology, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Cancer Mechanisms and Therapy (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Lymphoma Diagnosis and Treatment (5 papers), Cytokine Signaling Pathways and Interactions (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Metabolism and Genetic Disorders (3 papers) and RNA Research and Splicing (3 papers). The work is most often cited by research in Cancer Research (353 citations), Molecular Biology (873 citations), Genetics (83 citations), Oncology (213 citations) and Pathology and Forensic Medicine (125 citations). Carles Codony has collaborated with scholars based in Spain, Italy and United States. Frequent co-authors include John Byrne, Andrew J. Hamilton, Gurman S. Pall, Rafael Rosell, Niki Karachaliou, Jordi Codony‐Servat, Dolors Serra, Guillermina Asins, Fausto G. Hegardt and M.A. Bach. Their work appears in journals such as Journal of Thoracic Oncology, Blood, Translational Lung Cancer Research, Nature Communications and Biochemical Society Transactions.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact